Literature DB >> 262106

Airway response to carbachol in normal and asthmatic subjects: distinction between bronchial sensitivity and reactivity.

J Orehek, P Gayrard, A P Smith, C Grimaud, J Charpin.   

Abstract

By constructing cumulative dose-response curves to inhaled carbachol in 12 normal and 17 asthmatic subjects with comparable baseline specific airway conductance, we have shown that there were wide variations among subjects in the dose of carbachol needed to cause a 25 per cent decrease in specific airway conductance (bronchial sensitivity) and in the slopes of the curves (bronchial reactivity). Furthermore, there was no significant correlation between these 2 characteristics of the bronchial response to carbachol. The mean dose-response curves of the asthmatic and the normal subjects were widely divergent, indicating that the asthmatic subjects differed from normal subjects more in terms of bronchial reactivity than in bronchial sensitivity. This suggests that different mechanisms determine the sensitivity and reactivity of the bronchial tree, and that hyper-reactivity is the main feature of the asthmatic response. Both should be assessed when the bronchial response to bronchoconstrictor agents is measured.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 262106     DOI: 10.1164/arrd.1977.115.6.937

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  27 in total

Review 1.  Methodology of bronchial responsiveness.

Authors:  S Chinn
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

Review 2.  Measurement of bronchial responsiveness.

Authors:  C J Trigg; R J Davies
Journal:  Clin Rev Allergy       Date:  1989

3.  Protective effect of drugs on bronchoconstriction induced by sulphur dioxide.

Authors:  W C Tan; E Cripps; N Douglas; M F Sudlow
Journal:  Thorax       Date:  1982-09       Impact factor: 9.139

4.  Bronchial hyperresponsiveness following acute severe asthma.

Authors:  A Rabbat; J P Laaban; E Orvoën-Frija; M F Doré; A Achkar; J Rochemaure
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

5.  Potassium tolerance and bronchial reactivity in asthmatic and nonasthmatic atopic subjects.

Authors:  L Marazzini; R Cavestri; B Mastropasqua; M Bozzoni; M Pacetti; E Longhini
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

6.  Airway reactivity to bronchoconstrictor and bronchodilator: assessment using thin-section and volumetric three-dimensional CT.

Authors:  B K Han; J G Im; H S Kim; J M Koo; H D Kim; K M Yeon
Journal:  Korean J Radiol       Date:  2000 Jul-Sep       Impact factor: 3.500

7.  Histamine dose-response curves in asthma: reproducibility and sensitivity of different indices to assess response.

Authors:  P Dehaut; A Rachiele; R R Martin; J L Malo
Journal:  Thorax       Date:  1983-07       Impact factor: 9.139

8.  Prostaglandins and the control of airways responses to histamine in normal and asthmatic subjects.

Authors:  E H Walters
Journal:  Thorax       Date:  1983-03       Impact factor: 9.139

9.  Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects.

Authors:  S C Christiansen; D Proud; C G Cochrane
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

10.  Histamine dose-response curves in asthma: relevance of the distinction between PC20 and reactivity in characterising clinical state.

Authors:  A Beaupré; J L Malo
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.